ArticleScientific reports2025
Investigating the cytotoxicity of Aluminum-Doped zinc oxide nanoparticles in normal versus cancerous breast cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Green synthesis of ZnO/FeRSC advances · 2026Article
- Facile synthesis of zinc-coordinated lignin nanoparticles derived from sugarcane bagasse waste biomass for sustainable bioactive composites.Discover nano · 2026Article
- Synthesis and Biomedical Potential of TiCOBiological trace element research · 2026Article
- A multipurpose 1DZnO nanoplatform to combat ampicillin-resistant E. coli.Scientific reports · 2026Article
- Design and characterization of Zn-integrated cellulose nanoparticle derived from sugarcane bagasse for biomedical applications.Discover nano · 2026Article
- Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration.Journal of nanobiotechnology · 2026Review
- Advanced XRD peak broadening analysis of gallium-doped ZnO nanoparticles for crystallite size evaluation.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the concentration-dependent cytotoxicity of aluminum-doped zinc oxide nanoparticles on breast cancer (MDA-MB-231) and normal mammary epithelial cells (MCF-10 A). Pure and Al-doped ZnO nanoparticles (Al-ZnO NPs, Zn
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.